page 4 of THE WORLD'S TOP 100 INNOVATION LEADERS OF 2022 - WORLD BIZ MAGAZINE AWARDS
Chairman, President and Chief Executive Officer
Steve Rendle is Chairman, President and Chief Executive Officer at VF Corporation. He has more than 35 years of experience in the specialty outdoor and action sports industry, more than half of which have been with VF.
Steve was appointed CEO in January 2017 and then Chairman of VF’s Board of Directors in October 2017. Prior to being named CEO, he was President and Chief Operating Officer, overseeing all of VF's business coalitions worldwide: Outdoor and Action Sports, Jeanswear, Imagewear and Sportswear. He also was responsible for VF's Global Supply Chain and Direct-to-Consumer platforms.
Prior to becoming President and COO, Steve was Senior Vice President, Americas, and was responsible for driving strategies to support VF's continued growth in its Americas-based businesses. Previously, Steve spent three years as Group President, Outdoor and Action Sports Americas, leading VF's Outdoor and Action Sports businesses in North and South America. He also served as President of VF's Outdoor Americas coalition, where he oversaw The North Face®, JanSport®, Eagle Creek® and lucy® brands, as well as business development for the coalition.
Steve began his VF career with The North Face in 1999 and shortly afterward was promoted to Vice President of Sales, where he worked to reshape the business' sales organization, product and marketing strategies, and go-to-market model. In 2004, Steve was appointed President of The North Face brand, a role he held for seven years. Under Steve’s leadership, the brand expanded globally and experienced considerable growth from $483 million in 2004 to $1.6 billion in 2011.
Before joining The North Face, Steve held leading sales management roles at Youngone Corporation and at W.L. Gore and Associates.
Steve serves on the Board of Directors of Best Buy and the Retail Industry Leaders Association. He is a founding board member of the Outdoor Industry Association's Outdoor Foundation and has served in an advisory capacity to Bainbridge Graduate Institute where he provided insight into its creation of a Master of Business Administration program with a focused concentration on sustainability. In 2018, Steve was named CEO of the Year by Corporate Responsibility Magazine for his progressive environmental, social and governance agenda.
He earned a Bachelor of Science degree in Kinesiology from the University of Washington.
For more information about VF Corporation, visit: vfc.com
President and Chief Executive Officer
Sanjay Mehrotra is President and Chief Executive Officer at Micron Technology. Mr. Mehrotra joined Micron in May 2017, after a long and distinguished career at SanDisk Corporation where he led the company from start-up in 1988 until its eventual sale in 2016. In addition to being a SanDisk co-founder, Mr. Mehrotra served as its president and CEO from 2011 to 2016, overseeing its growth to an industry-leading Fortune 500 company. He also served as a member of its board of directors from July 2010 to May 2016.
Prior to SanDisk, Mr. Mehrotra held design engineering positions at Integrated Device Technology, Inc., SEEQ Technology and Intel Corporation. Within the past five years, Mr. Mehrotra served on the board of directors of Cavium, Inc., and currently serves on the board of CDW Corporation.
Mr. Mehrotra earned both bachelor’s and master’s degrees in electrical engineering and computer science from the University of California, Berkeley and is a graduate of the Stanford Graduate School of Business Executive Program (SEP). Mr. Mehrotra holds more than 70 patents and has published articles in the areas of nonvolatile memory design and flash memory systems.
For more information about Micron Technology, visit: micron.com
Dr. Tom Leighton
Chief Executive Officer and Co-Founder
Dr. Tom Leighton co-founded Akamai Technologies in 1998 and served as Akamai’s Chief Scientist until he became CEO in 2013. Under Dr. Leighton’s leadership, Akamai has evolved from its origins as a Content Delivery Network (CDN) into one of the most essential and trusted cloud delivery and cybersecurity platforms, upon which many of the world’s best brands and enterprises build and secure their digital experiences. During his time as CEO, Akamai’s revenue has more than doubled, growing from less than $1.4 billion in 2012 to $3.2 billion in 2020, while earnings per share has more than tripled. Over the same period, annual revenue from Akamai’s security business grew from less than $25 million to more than $1 billion, growing 25% year-over-year in 2020.
As one of the world's preeminent authorities on algorithms for network applications and cybersecurity, Dr. Leighton discovered a solution to freeing up web congestion using applied mathematics and distributed computing. Akamai used this technology to create the world's largest distributed computing platform, which today delivers and secures tens of millions of requests per second to billions of users around the world.
Dr. Leighton holds more than 50 patents involving content delivery, Internet protocols, algorithms for networks, cryptography and digital rights management. He and Akamai’s co-founder Danny Lewin were inducted into the National Inventors Hall of Fame in 2017 for having “invented the methods needed to intelligently replicate and deliver content over a large network of distributed servers, technology that would ultimately solve what was becoming a frustrating problem for Internet users known as the ‘World Wide Wait.’” In 2018, the Marconi Society selected him to receive the Marconi Prize for “his fundamental contributions to technology and the establishment of content delivery networks.” He is also a member of the National Academy of Sciences, the National Academy of Engineers, and the American Academy of Arts and Sciences.
Dr. Leighton has served on numerous government, industry and academic advisory panels. He was one of 18 CEOs invited to the White House in 2017 for the launch of the American Technology Council to develop solutions to modernize and secure the U.S. government’s IT systems. From 2003 to 2005, he served on the President's Information Technology Advisory Committee and chaired its Subcommittee on Cybersecurity. He is also a member of the National Academy of Sciences, the National Academy of Engineering, and the American Academy of Arts and Sciences.
Dr. Leighton has been personally committed to increasing the pipeline of students pursuing STEM careers for over thirty years, first as a mathematics professor at MIT and now through his leadership at Akamai. He is a strong supporter of the Akamai Foundation, which promotes mathematics education, and he oversaw the creation of the Akamai Technical Academy, an innovative program developed in-house, aimed at training diverse non-technical professionals for technical careers. He also supports numerous charitable organizations dedicated to improving STEM education and opportunities for K-12 students, including The Center for Excellence in Education, the Society for Science and the Public (sponsor of the Intel Science Search), The Mathematical Association of America (sponsor of the Math Olympiad), the Math Competition for Girls, and Girls Who Code.
Dr. Leighton graduated summa cum laude from Princeton University in 1978 with a B.S.E. in Electrical Engineering and Computer Science. He received his Ph.D. in Applied Mathematics from MIT in 1981.
For more information about Akamai Technologies, visit: akamai.com
Gregory J. Hayes
Chairman and Chief Executive Officer
Raytheon Technologies Corporation
Gregory J. Hayes is the chairman and chief executive officer of Raytheon Technologies Corporation, responsible for leading an aerospace and defense company of 180,000 employees and $64 billion in annual sales.
Elected chairman of the board in 2021, Hayes had a nearly 21-year career at United Technologies Corporation, holding several senior leadership roles across finance, corporate strategy and business development, culminating with his appointment to chief executive officer in 2014 and chairman in 2016. As CEO, Hayes led the reshaping of UTC from industrial conglomerate to focused aerospace company. Beginning with the divestiture of Sikorsky Aircraft in 2015 and the acquisition of Rockwell Collins in 2018, Hayes continued to focus the business with the spinoffs of Otis Elevator Company and Carrier Corporation in 2020. Hayes then led the merger of UTC’s remaining aerospace businesses, Pratt & Whitney and Collins Aerospace Systems, with Raytheon Company, to form Raytheon Technologies in April 2020.
Hayes, who joined UTC in 1999 through its merger with the Sundstrand Corporation, also served as UTC’s chief financial officer from 2008-2014.
Hayes holds a bachelor’s degree in economics from Purdue University and is a Certified Public Accountant.
For more information about Raytheon Technologies Corporation, visit: rtx.com
Chief Executive Officer
Gerrit Marx has more than 20 years of experience in roles of increasing importance in different locations around the world and in a variety of industrial segments, with a specific in-depth focus on automotive industries. He holds a degree in Mechanical Engineering (“Diplom Ingenieur”) and an MBA (“Diplom Kaufmann”) from RWTH Aachen University, and a Doctorate in Business Administration from Cologne University.
From 1999 to 2007, Mr. Marx worked at the global consulting firm McKinsey & Company, focusing on operational improvement programmes in the automotive and aerospace industries in Europe, Brazil, and Japan.
He joined Daimler AG in 2007 to head the global controlling function for vehicle and powertrain component projects, as well as market-entry / mergers and acquisitions for three truck brands in North America, Europe, and Asia. This led him to the role of President and Chief Executive Officer at Daimler Trucks China in 2009 and subsequently, President of Skoda China with Volkswagen AG, overseeing imports and joint venture business relations in both roles.
In 2012 Mr. Marx joined the European leadership team of Bain Capital as a member of their portfolio group, driving and leading transformational change programs. This role also encompassed due diligence and merger and acquisition activities, with specific focus on automotive and industrial assets, and also included interim roles such as Chief Executive Officer of Wittur Group, a global Tier-1 supplier to the elevator industry.
Gerrit Marx joined CNH Industrial in January 2019 as President of Commercial and Specialty Vehicles. Since the spin-off of Iveco Group from CNH Industrial on 1st January 2022, Mr. Marx has served as Chief Executive Officer of the newly formed Company.
For more information about Iveco Group, visit: ivecogroup.com
Chief Executive Officer
Trading Technologies International
Software-as-a-Service is integral to Keith Todd’s DNA. Roughly half of his 40-year career has focused on SaaS, spanning global technology businesses from publicly listed and large multinational companies to start-ups. As TT’s CEO, Keith oversees day-to-day operations, driving the firm’s global growth strategy and execution.
Prior to TT, Keith served as CEO and remains Executive Chairman of KRM22. He was Executive Chairman and CEO of FFastFill, a global derivatives SaaS provider acquired by ION Group, as well as Executive Chairman of ION Agency Trading. His career also includes leadership positions with Marconi Defense Group and ICL plc, among others. He was also Chairman of the UK Broadband Stakeholder Group.
Keith was awarded the CBE (Commander of the Order of the British Empire) by the Queen of England for his services to the telecommunications industry. He is a fellow of the Chartered Institute of Management Accountants (FCMA).
For more information about Trading Technologies, visit: tradingtechnologies.com
Dr. Jurgi Camblong
Founder and Chief Executive Officer
Dr. Jurgi Camblong is a visionary entrepreneur who is pioneering the data-driven medicine movement around the world. He is a molecular biologist (published in Cell, Science and Nature), has a PhD in life sciences from the University of Geneva and an EMBA in management of technology from EPFL/HEC Lausanne.
In 2011, he founded SOPHiA GENETICS with Dr. Pierre Hutter and Prof. Lars Steinmetz. He has since successfully led the development of the company, listed among the 50 Smartest Companies by the MIT Technology Review. Jurgi has been a member of the Advisory Council on Digital Transformation to the Swiss government and was personally recognized by EY as Emergent Entrepreneur of the Year in 2017.
For more information about SOPHiA GENETICS, visit: sophiagenetics.com
Jeffrey K. Storey
President and Chief Executive Officer
Jeffrey K. Storey is a transformational telecommunications and cybersecurity innovator serving as the President and Chief Executive Officer of Lumen since 2018; as the Chief Operating Officer of Lumen between 2017 and 2018 and prior to his current role having served as President and Chief Executive Officer of Level 3 Communications, Inc. from April 2013 to November 2017; President and Chief Operating Officer of Level 3 Communications, Inc. from December 2008 to April 2013; President of Leucadia Telecommunications Group (Leucadia National Corporation) from 2006 to 2008; Chief Executive Officer and President of WilTel Communications Group Inc. from 2002 to 2005 and in various other senior level positions with WilTel or its affiliates from 1999 to 2002; Vice President of Commercial Services of Cox Communications from 1998 to 1999 and as a Vice President and General Manager of Cox Fibernet from 1994 to 1998.
Mr. Storey began his career in telecommunications in 1983 with Southwestern Bell Telephone where he held various engineering and operations positions. In the last five years he served on the public company board of Level 3 Communications, Inc. from 2013 to 2017 and his other leadership experience includes serving on the National Security Telecommunications Advisory Committee.
For more information about Lumen, visit: lumen.com
Chief Executive Officer and Co-Founder
Rafal Modrzewski is Chief Executive Officer of ICEYE, which he co-founded with Pekka Laurila as a project in 2012 and a company in 2014. Rafal is in charge of overseeing growth and implementing ICEYE’s ambitious vision, which he does with deep expertise in Synthetic Aperture Radar (SAR) engineering. Like everyone at ICEYE, he’s committed to empowering commercial and government partners with unmatched persistent monitoring capabilities for any location on Earth, enabling them to make timely, data-driven decisions to solve challenges, ensure infrastructure, and protect the environment.
The Story of ICEYE is not about us. It is about you. The story of ICEYE is about the users of our Earth observation data. Individuals within government and business organisations, who are solving some of the hardest problems the world faces today.
For more information about ICEYE, visit: iceye.com
James A. May II
President and Chief Executive Officer
James May joined REC Silicon in 2008. Mr. May holds Bachelor's degrees in Business Administration and Accounting from Boise State University. Prior to REC Silicon, Mr. May worked for Hewlett Packard, was a partner in a Pocatello, Idaho regional public accounting firm, and was the Director of Finance for European Operations and the Director of Financial Planning and Analysis for the Chemical Division of Kerr-McGee.
REC Silicon is a global leader in silane-based, high-purity silicon materials. REC Silicon ASA is a leading producer of advanced silicon materials, supplying high-purity polysilicon and silicon gases to the solar and electronics industries worldwide. We combine over 30 years' experience and best-in-class proprietary technology to deliver on customer expectations. Our two U.S. based plants have a capacity of more than 20,000 MT high-purity polysilicon. REC Silicon is headquartered in Fornebu, Norway and listed on the Oslo stock exchange under the ticker: REC.
For more information about REC Silicon, visit: recsilicon.com
Dr. Reshma Kewalramani
Chief Executive Officer, President, Director
Reshma Kewalramani, M.D., FASN, is the Chief Executive Officer and President at Vertex. Dr. Kewalramani has dedicated her career to improving the lives of patients, including the last 15+ years through the development of new medicines. She joined Vertex in 2017 and was previously the Chief Medical Officer and Executive Vice President of Global Medicines Development and Medical Affairs. Under Dr. Kewalramani’s leadership, Vertex also advanced several programs outside of CF into the clinic, including alpha-1 antitrypsin deficiency, APOL1-mediated kidney diseases, sickle cell disease and beta-thalassemia.
Prior to Vertex, Dr. Kewalramani spent more than 12 years at Amgen where she held a variety of roles across Research and Development, including as Vice President, Global Clinical Development, Nephrology & Metabolic Therapeutic Area and Vice President, U.S. Medical Organization. Dr. Kewalramani completed her internship and residency in Internal Medicine at the Massachusetts General Hospital and her fellowship in Nephrology at the Massachusetts General Hospital and Brigham and Women’s Hospital combined program.
Dr. Kewalramani received her medical degree, with honors, from the seven-year medicine program at the Boston University School of Medicine and completed the General Management Program at Harvard Business School.
For more information about Vetex Pharmaceuticals, visit: vrtx.com
President and Chief Executive Officer
Appointed as President, Chief Executive Officer and a Director of Enbridge in 2012, Al Monaco has led Enbridge through a period of unprecedented growth combined with a continued focus on safety, reliability and environmental protection that has positioned it as North America’s leading energy infrastructure company.
Under Al’s leadership, Enbridge has focused on long-term sustainable growth while maintaining the company’s low-risk business model. In 2017, Enbridge completed the $37-billion acquisition of Spectra Energy, which diversified the company, accelerated its natural gas strategy and expanded its U.S. footprint. Enbridge has invested more than $60 billion in energy infrastructure projects over the last seven years, including Canada’s first export pipeline system to the U.S. Gulf Coast, and the company’s first international offshore wind project.
Enbridge has prioritized sustainability by containing emissions from its operations and diversifying its asset base to reflect the global energy mix. Enbridge has developed an industry-leading approach to stakeholder and Indigenous engagement based on trust, collaboration and economic partnerships. Al is a strong advocate for building diverse and inclusive working environments and has signed Enbridge to Equal by 30, a pledge to support gender equality in the energy sector by 2030.
Al is a champion of North America’s energy industry and its ability to become a global leader by supplying affordable, reliable and responsible energy to the world. He is a Director and member of the American Petroleum Institute Executive and Finance Committees; a Director and member of the Weyerhaeuser Board and its Compensation Committee; and a member of the Business Council (US); the U.S. National Petroleum Council, the Business Council of Canada, the Business Council of Alberta, and the Catalyst Canada Advisory Board.
Al was the recipient of the Fraser Institute Founders Award (2019), and has been recognized as “Canadian Energy Person of the Year” (2017) and “Alberta Business Person of the Year” (2016) by the Energy Council of Canada and Alberta Venture, respectively.
Al is a staunch supporter of the community, including the United Way and the annual Enbridge Ride to Conquer Cancer. Al and his wife Laurie live in Calgary and have three sons.
Al earned a Master of Business Administration from the Haskayne School of Business (Finance) at the University of Calgary. He holds a CPA, CMA designation and is a member of the Chartered Professional Accountants of Alberta. He completed the Advanced Management Program at Harvard Business School.
For more information about Enbridge, visit: enbridge.com
President and Chief Executive Officer
Alaska Air Group
Ben Minicucci serves as chief executive officer of Alaska Air Group, the parent company of Alaska Airlines and Horizon Air. The combined airlines carry over 45 million guests a year on 1,300 daily flights to 115 destinations throughout the United States and to Canada, Mexico and Costa Rica.
Under the leadership of Ben and his team, Alaska is focused on low fares, profitable growth of the route network, and creating an airline people love. During Ben’s 17-year career with Alaska, he has contributed in various roles of increasing responsibility, becoming CEO on March 31, 2021.
In 2016, he was promoted to president of Alaska Airlines, and was also named CEO of Virgin America upon Alaska’s acquisition of the airline in December 2016 until the airlines merged under a single operating certificate in January 2018. He oversaw the integration of Alaska and Virgin America’s operations, processes and work groups. As president of Alaska, Ben was responsible for both operations and commercial functions. He led the execution of the company’s strategic plan including a focus on Alaska’s network, flight schedule, sales, revenue management, safety and operations, marketing and real estate.
In 2009, he was promoted to executive vice president and chief operating officer. During this time, he directed the implementation of a customer service-guiding framework, which empowers employees to deliver personal and kind-hearted experiences to guests, recognizing their unique circumstances instead of being bound by rigid company policies. In 2007, Ben was named vice president of Seattle operations. He implemented an operational management process called the turn timeline which dramatically increased Alaska’s on-time performance and reliability. Ben joined Alaska in 2004 as staff vice president of maintenance.
Before joining Alaska, Ben spent seven years serving in a variety of roles at Air Canada’s technical operations and, ultimately, vice president of heavy maintenance. He served in the Canadian Armed Forces for 14 years prior to joining the private aviation sector.
Ben holds a bachelor’s and master’s degree in mechanical engineering from the Royal Military College of Canada. He’s currently on the board of directors for Alaska Air Group, Washington Roundtable, and the University of Washington Michael G. Foster School of Business Center for Leadership & Strategic Thinking.
For more information about Alaska Air, visit: alaskaair.com
Chairman, President and Chief Executive Officer
Hervé Hoppenot joined Incyte in 2014 as President and Chief Executive Officer, and was appointed Chairman of the Board of Directors in 2015.
During Mr. Hoppenot’s tenure, the Company has tripled the number of clinical candidates in its portfolio, expanding beyond oncology to include research and development in inflammation & autoimmunity. Under his leadership, revenue has increased by over 500 percent, which includes the addition of 5 new revenue sources of potential revenue; and, with a goal to deliver medicines to patients worldwide, the Company has expanded geographically beyond the U.S. to include operations in Canada, 10 European countries, Japan and China.
Prior to joining Incyte, Mr. Hoppenot was the President of Novartis Oncology. Prior to joining Novartis in 2003, Mr. Hoppenot started his career in 1983 with Rhone Poulenc, later known as Aventis, where he served in several senior roles of increasing responsibility, including Vice President of Oncology and Head of the U.S. Oncology business unit. Mr. Hoppenot holds a diploma from ESSEC Business School.
For more information about Incyte, visit: incyte.com
Leonard S. Schleifer
Fonder, President and Chief Executive Officer
Leonard S. Schleifer, MD, PhD, founded Regeneron in 1988, has been a Director and the company’s President and Chief Executive Officer since its inception. He served as Chairman of the Board from 1990 through 1994. Dr. Schleifer, together with Dr. Yancopoulos, has grown Regeneron from a tiny startup into a ~$50 billion market cap company, with a unique science-driven culture, successful drug discovery and development engine and nine FDA-approved medicines.
Dr. Schleifer has been recognized as one of Barron’s Best CEOs and as an Ernst & Young Entrepreneur of the Year. He graduated from Cornell University and earned his MD and PhD in Pharmacology from the University of Virginia. Dr. Schleifer is a licensed physician, certified in Neurology by the American Board of Psychiatry and Neurology, and worked as a practicing neurologist before founding Regeneron.
Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for nearly 35 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development, nearly all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic diseases, infectious diseases and rare diseases.
Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune®, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies, and through ambitious research initiatives such as the Regeneron Genetics Center®, which is conducting one of the largest genetics sequencing efforts in the world.
For more information about Regeneron, visit: regeneron.com
Chief Executive Officer and Chairman
Ron Clarke has been our Chief Executive Officer since August 2000 and was appointed Chairman of our Board of Directors in March 2003. From 1999 to 2000, Ron served as President and Chief Operating Officer of AHL Services, Inc., a staffing firm. From 1990 to 1998, Ron served as Chief Marketing Officer and later as a Division President with Automatic Data Processing, Inc., a computer services company. From 1987 to 1990, Ron was a Principal with Booz Allen Hamilton, a global management consulting firm. Earlier in his career, Ron was a marketing manager for General Electric Company, a diversified technology, media, and financial services corporation.
Businesses power the global economy. FLEETCOR powers the global business payment industry, processing billions of transactions each year in more than 100 countries. Tapping into our network of more than 800,000 vendors who already accept electronic payments, FLEETCOR is shaping the future of global business payments.
For more information about FleetCor Technologies, visit: fleetcor.com
Co-founder, Executive Chairman of the Board
James Liang is one of the Co-founders and Executive Chairman of the Board of Trip.com Group Ltd. He was the Chief Executive Officer from 2000 to 2006 and from 2013 to 2016. Under his visionary leadership, Trip.com Group has achieved great milestones over the years. The company has successfully carried out transitions from offline to online, and from desktop to mobile.
Furthermore, Trip.com Group has made strategic investments in key industry players, cultivated and invested in new business ideas, and established industry-leading operational standards and processes. Trip.com Group has grown to become one of the world's largest online travel agencies. James has been awarded various accolades for his contributions to the travel industry. Some of his recent awards include: 2019 Forbes China Multinational Business Leader, Best CEO in the Internet category in the 2016 All-Asia Executive Team Rankings by Institutional Investor.
Currently, James serves as Co-Chairman of Tongcheng-eLong (HKSE:0780) and on the boards of a number of other Internet companies, including Sina (NASDAQ: SINA), and MakeMyTrip (NASDAQ: MMYT). Prior to co-founding Trip.com Group, James held a number of technical and managerial positions at Oracle Corporation from 1991 to 1999, both in the United States and China. He was the head of the ERP consulting division of Oracle China from 1997 to 1999. James received his Ph.D. degree from Stanford University and his master's and bachelor's degrees from Georgia Institute of Technology. He was also an attendee of the "China Gifted Youth Class" at Fudan University.
For more information about Trip.com Group, visit: group.trip.com
Joseph M. Hogan
Director, President and Chief Executive Officer
Joseph M. Hogan joined Align in June 2015 as President, Chief Executive Officer (CEO), and a Director of Align Technology. Mr. Hogan is an accomplished chief executive with extensive experience across multiple industries including healthcare, technology and industrial automation.
Before joining Align, Mr. Hogan served as CEO of ABB, a $40 billion global power and automation technologies company based in Zurich, Switzerland. During his five years at ABB, Mr. Hogan oversaw a 25% increase in revenues. Prior to ABB, Mr. Hogan spent 25 years at General Electric (GE) in a variety of executive and management roles, including eight years as CEO of GE Healthcare, where he drove significant geographic and market portfolio expansion and more than doubled revenues from $7 billion to $16 billion. Mr. Hogan earned an M.B.A. from Robert Morris University and a B.S. degree in Business and Economics from Geneva College, both in Pennsylvania.
Align Technology is a global medical device company that is changing lives through better smiles. We reimagine and reinvent the way orthodontic and restorative treatment is presented and delivered to millions of people around the world. We believe a better smile has the power to create a better future, so we create digital technology and experiences to help people move forward in life.
For more information about Align Technology, visit: aligntech.com
Li Faben, born in 1964, is a professor and senior engineer. He graduated from Central South Mining and Metallurgy College (now Central South University) - with a bachelor's degree in mining engineering in 1983 and from Xi’an University of Architecture and Technology - with a master's degree in -the same major in 2004. He obtained a doctor's degree in management science and engineering in January 2014. At CMOC, he was the Executive Deputy General Manager from August 2006 to October 2012 and began to serve as an executive director in August 2006 and as General Manager and member of the Strategy and Sustainability Committee in October 2012.
CMOC Group Limited was created in 1969 and after mixed ownership reforms in 2004 and 2014, has become a private holding company with state-owned capital participation. The Company was listed on Hong Kong Exchanges (HKEX: 03993) and Shanghai Stock Exchange (SSE: 603993) in 2007 and 2012, respectively.
Focused on non-ferrous metal mining, CMOC specializes in mining and trading of base and rare metals in the world. With its main business presence on five continents: Asia, Africa, South America, Oceania and Europe, the company is the largest tungsten producer, the second largest cobalt and niobium producer, one of the top seven molybdenum producers and a leading copper producer in the world. It is also the second largest producer of phosphatic fertilizers in Brazil. In terms of trading business, the company is among the top three base metal merchants in the world.
The company's vision is to become the most respected world-class resources company. It focuses on building a management concept that features meritocracy, cost control, continuous improvement, and achievement sharing. The corporate strategies include: maintaining and strengthening competitive cost advantages of existing business; continuously managing and optimizing the balance sheet; creating synergy while ensuring stable domestic and overseas operations; focusing on value creation and structural and growth pattern transformation, continuing to acquire, develop and invest in resources projects.
For more information about CMOC Group, visit: cmoc.com
Gary S. Guthart
Chief Executive Officer
Gary S. Guthart, Ph.D., is chief executive officer at Intuitive and a member of the Board of Directors, roles he has held since 2010. He draws from more than 25 years of medical, engineering, scientific, and management experience.
Dr. Guthart joined the company as part of the first engineering team in 1996 as a Control Systems Analyst. He was promoted to vice president of engineering in 1999, senior vice president of product operations in 2002, and four years later, he was appointed President and Chief Operating Officer.
Before joining Intuitive, Guthart was part of the core team developing foundational technology for computer-enhanced surgery at SRI International (formerly Stanford Research Institute), a renowned nonprofit scientific research organization. While at SRI, he also developed algorithms for vibration and acoustic control of large-scale systems. Guthart’s first scientific experience came early in his career in a Human Factors Lab at NASA, supporting a team studying human performance assessment of pilots.
Guthart is on the Board of Directors for Illumina, and is also a member of the Board of Directors for the Silicon Valley Leadership Group.
Guthart received a B.S. in engineering from the University of California, Berkeley. He earned an M.S. and a Ph.D. in engineering science from the California Institute of Technology.
For more information about Intuitive Surgical, visit: intuitive.com
President and Chief Executive Officer
Neil Hunn has been President and Chief Executive Officer since August of 2018. Prior to becoming President and CEO Mr. Hunn served as Executive Vice President and COO. Mr. Hunn started with Roper in 2011 as Group Vice President with Roper Technologies’ medical segment and has helped drive the growth in the Company’s medical technology and application software businesses. Prior to joining Roper, Mr. Hunn served 10 years as Executive Vice President and CFO at MedAssets, an Atlanta-based SaaS company, and as President of its revenue cycle technology businesses. He successfully led MedAssets’ initial public offering and the execution of several M&A transactions. Mr. Hunn earned his MBA from Harvard Business School and his bachelor’s degree in finance and accounting from Miami University (Ohio).
For more information about Roper Technologies, visit: ropertech.com
Michael A. Mussallem
Chairman and Chief Executive Officer
Michael A. Mussallem was appointed chairman and chief executive officer of Edwards Lifesciences in 2000, when it became an independent, publicly traded company. Under his leadership, Edwards has established its position as a global leader in patient-focused medical innovations with the introduction of lifesaving and life-sustaining therapies such as transcatheter aortic valve replacement, new resilient surgical valves designed for active patients and non-invasive hemodynamic monitoring.
Driven by a passion to help patients, the company collaborates with the world's leading clinicians and researchers to address unmet healthcare needs, working to improve patient outcomes and enhance lives while delivering value to the healthcare system. Mussallem has not only led the development and successful implementation of the company’s patient-focused innovation strategy, but also established Edwards’ commitment to philanthropy and corporate social responsibility.
Since 2004, the company and Edwards Lifesciences Foundation have gifted almost $90 million to non-profit organizations around the world supporting underserved patients and strengthening communities where its employees live and work. In 2014, Edwards Lifesciences Foundation launched Every Heartbeat Matters, which has impacted more than 1.7 million underserved people and aims to improve the lives of 2.5 million additional underserved structural heart and critical care patients by the end of 2025. During Mussallem’s tenure, Edwards has been recognized among the World’s Most Ethical Companies by the Ethisphere Institute, an organization that defines and advances standards of ethical business practices. In 2019, Edwards was named as one of the Management Top 250 by The Wall Street Journal in partnership with the Drucker Institute, and was also cited as one of the 8 “all stars” achieving high marks in five dimensions of corporate performance.
Mussallem has been honored by the Harvard Business Review in its annual Best-Performing CEOs in the World list, including, most recently, in 2019. He has received a number of honors including the UC Irvine Medal, a lifetime achievement award from The Phoenix Conference and the Wenger Award for Excellence in Corporate Leadership by WomenHeart. Prior to his current position, Mussallem held a variety of positions at Baxter International from 1979 until 2000, when Edwards was spun off from Baxter.
Currently, Mussallem serves on the board of the Advanced Medical Technology Association (AdvaMed) and is an advisory board member for the Leonard D. Schaeffer Center for Health Policy & Economics at the University of Southern California. He is a trustee of the University of California, Irvine Foundation and the Rose-Hulman Institute of Technology in Terre Haute, Indiana. Mussallem has served as board chairman of both AdvaMed and the California Healthcare Institute (CHI). In 2004, he joined the board of the Edwards Lifesciences Foundation. He received a bachelor's degree in chemical engineering and an honorary doctorate degree from the Rose-Hulman Institute of Technology.
For more information about Edwards Lifesciences, visit: edwards.com
Chairman and Chief Executive Officer
Martin Mucci is chairman of the board and chief executive officer for Paychex. The Board of Directors appointed Mucci as chair in December 2021 in addition to his responsibilities as CEO.
Under Mucci’s leadership, Paychex has significantly expanded upon its foundation as a payroll services company to become a leading provider of integrated human capital management software solutions for more than 710,000 small and mid-sized businesses, growing to over $4 billion in annual revenue and a market cap of over $42 billion.
In his time as CEO, Paychex has transformed into a technology-enabled service company. Combining innovative software-as-a-service technology with dedicated, personalized service, Paychex empowers business owners to focus on the growth and success of their business, instead of contending with the demands of HR, payroll, and benefits administration.
Mucci is a frequent guest on CNBC and other major networks where he regularly discusses U.S. small business conditions, citing insights from the Paychex | IHS Markit Small Business Employment Watch, a monthly report of aggregated hiring and wage data from more than 350,000 Paychex clients with fewer than 50 employees.
Mucci was named president and CEO of Paychex in September 2010. He joined the company as senior vice president of operations in October 2002.
Prior to Paychex, Mucci served as president of telephone operations for Frontier Communications and CEO of Frontier Telephone of Rochester, N.Y. – both telecommunications services providers.
Mucci holds a bachelor’s degree in accounting from St. John Fisher College in Rochester, N.Y. and earned a master’s degree in business administration from the William E. Simon Graduate School of Business at the University of Rochester. Mucci is a member of the Board of Directors for NCR Corp. and on the advisory team for Madison Dearborn Partners, LLC, a leading private equity investment firm based in Chicago. A longtime community advocate, Mucci has served as a member of the Greater Rochester Chamber of Commerce Executive Committee and as chairman of the United Way of Greater Rochester annual campaign, the Rochester American Heart Association’s Heart Walk and Run, and JDRF’s Walk to Cure Juvenile Diabetes.
For more information about Paychex, visit: paychex.com
Siobhán Talbot was appointed as Group Managing Director on 12 November 2013, having been appointed Group Managing Director Designate on 1 June 2013.
She was previously Group Finance Director and her role encompassed responsibility for Group strategic planning. She has been a member of the Group Operating Executive since 2000 and the Board since 2009 and has held a number of senior positions since she joined the Group in 1992.
She is also a Director of the Irish Business Employers’ Confederation (IBEC) and was appointed as a Non-Executive Director of CRH plc effective 1 December 2018. Prior to joining Glanbia, she worked with PricewaterhouseCoopers in Dublin and Sydney. A fellow of Chartered Accountants Ireland, Siobhán graduated from University College Dublin with a Bachelor of Commerce degree and Diploma in Professional Accounting.
Glanbia: We are dedicated to delivering better nutrition for every step of life’s journey. That means we are curious about finding ways to make better, healthier and smarter products that fit the lifestyles and needs of people around the world. We are constantly innovating, developing and reinventing, creating products that fit easily into people’s daily lives. The desire to do better is embedded in our business.
For more information about Glanbia, visit: glanbia.com
Richard A. Gonzalez
Chairman and Chief Executive Officer
Richard A. Gonzalez is Chairman of the Board and Chief Executive Officer of AbbVie, a global biopharmaceutical company that employs approximately 50,000 people worldwide and markets medicines in more than 175 countries.
Prior to AbbVie’s separation from Abbott in January 2013, Mr. Gonzalez was a 30-year Abbott veteran. He served as President and Chief Operating Officer of Abbott before briefly retiring in 2007. He also held various senior leadership positions in Abbott’s medical products businesses, including President and Chief Operating Officer of the Medical Products Group; Senior Vice President and President of the former Hospital Products Division; Vice President and President of the Health Systems Division; and Divisional Vice President and General Manager for Diagnostics Operations in the United States and Canada.
Mr. Gonzalez has been a long-standing leader in the greater Chicago community where he is a member of the Commercial Club of Chicago and represents AbbVie on their Civic Committee. He is also a member of the Business Roundtable, which is the only national organization representing exclusively CEOs of America’s leading companies.
For more information about AbbVie, visit: abbvie.com